Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The European Journal of Neuroscience|October 31, 2002
EphB receptors influence growth of ephrin-B1-positive statoacoustic nerve fibersLynne M Bianchi, Neil A Gray
Pharmacological Research|May 29, 2003
Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant miceTodd D Gould, Neil A Gray, Husseini K Manji
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 2008
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorderJorge A Quiroz, Neil A Gray, Tadafumi Kato, et al.
The Journal of Clinical Psychiatry|May 2, 2003
The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disordersNeil A Gray, Rulun Zhou, Jing Du, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expressionJing Du, Neil A Gray, Cynthia Falke, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor traffickingJing Du, Jorge A Quiroz, Neil A Gray, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 23, 2004
Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expressionJing Du, Neil A Gray, Cynthia A Falke, et al.
Biological Psychiatry|February 5, 2013
Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorderNeil A Gray, Matthew S Milak, Christine DeLorenzo, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic systemCarlos A Zarate, Jing Du, Jorge Quiroz, et al.
Biological Psychiatry|April 23, 2003
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depressionHusseini K Manji, Jorge A Quiroz, Jonathan Sporn, et al.
Pageof 2